PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s Harvard Bioscience HBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.38K Hold
225
﹤0.01% 510
2026
Q1
$1.1K Hold
225
﹤0.01% 482
2025
Q4
$1.5K Hold
225
﹤0.01% 484
2025
Q3
$987 Sell
225
-370
-62% -$1.75K ﹤0.01% 506
2025
Q2
$2.64K Hold
595
﹤0.01% 422
2025
Q1
$3.37K Hold
595
﹤0.01% 400
2024
Q4
$12.6K Buy
595
+57
+11% +$1.31K 0.01% 356
2024
Q3
$14.5K Buy
+538
New +$15.8K 0.01% 286

Other funds holding HBIO

PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s HBIO Position: Q2 2026 in Review

PENSION & WEALTH MANAGEMENT ADVISORS, INC. held its Harvard Bioscience (HBIO) position steady in Q2 2026 at 225 shares worth $1.38K. The position accounts for ﹤0.01% of the portfolio, ranked #510.

PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in HBIO in Q3 2024 and has held it in 8 quarters since. The position peaked at $14.5K in Q3 2024. 8 funds tracked by Wall St. Rank hold HBIO as of Q2 2026.

  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. held 225 shares of Harvard Bioscience worth $1.38K as of Q2 2026.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. left its Harvard Bioscience share count unchanged in Q2 2026.
  • Harvard Bioscience made up ﹤0.01% of PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s portfolio in Q2 2026, its #510 holding.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in Harvard Bioscience in Q3 2024 and has held it in 8 quarters since.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s Harvard Bioscience position peaked at $14.5K in Q3 2024.
  • 8 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2026.

Based on PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s 13F filing for Q2 2026, filed 7 Aug 2026.